Novo Nordisk A/S (TSX:NOVO)
19.66
-1.29 (-6.16%)
At close: Feb 4, 2026
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of CAD 292.55 billion as of February 5, 2026. Its market cap has decreased by -44.91% in one year.
Market Cap
292.55B
Enterprise Value
315.02B
Revenue
66.62B
Ranking
n/a
PE Ratio
13.25
Stock Price
19.66
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 9.70B to 292.55B, an increase of 2,915.52%. That is a compound annual growth rate of 12.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 352.73B | 13.24% |
| Dec 30, 2025 | 311.50B | -43.89% |
| Dec 30, 2024 | 555.20B | -8.91% |
| Dec 29, 2023 | 609.54B | 47.94% |
| Dec 30, 2022 | 412.02B | 26.32% |
| Dec 30, 2021 | 326.16B | 56.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.30B |
| Extendicare | 2.26B |
| Sienna Senior Living | 2.16B |
| Green Thumb Industries | 2.11B |
| Trulieve Cannabis | 1.66B |
| Cronos Group | 1.31B |
| Bright Minds Biosciences | 1.08B |
| WELL Health Technologies | 1.01B |